Home/Protocols/Semax
Protocol Reference
Human trial data

Semax protocol

Semax (ACTH 4-10 analog). Dosing on this page comes from a published human trial or an approved product label, cited below.

Category
Cognitive & Neuro
Common vials
10 mg
Half-life
Short
Route in the literature
Intranasal in registered use
Evidence level
Human trial data

How Semax works

A synthetic analog of the ACTH 4-10 fragment with a Pro-Gly-Pro tail that resists enzymatic breakdown. It has no corticotropic activity — the adrenal-stimulating part of ACTH is absent — and is studied for effects on BDNF expression.

Semax dosing schedule

Semax is a registered medicine in Russia, where it is supplied as an intranasal solution and used in stroke and cognitive indications. Two caveats matter: the clinical literature is largely Russian-language and has limited independent Western replication, and the registered product is intranasal drops — not the injectable vial sold as a research chemical.

PhaseAmountFrequencyNotes
Registered intranasal use0.1% solutionDrops per nostril, several times dailyThe registered presentation. Amounts are expressed as drops of a stated concentration, not as an injected mg figure.
Higher-concentration form1% solutionIntranasal, acute stroke settingA stronger presentation used in the acute neurological indications.

Study length: Course lengths of 10–14 days are typical in the published Russian clinical work.

Source for this schedule: Semax clinical literature (Russian registration, ischaemic stroke and cognitive indications). This reproduces what was administered in that work. It is reference information about a study, not a recommendation, and the trial population, monitoring and endpoints are part of what made it a protocol.

Reconstitution and measurement

This part is arithmetic and does not depend on the evidence level. Concentration is vial size divided by the bacteriostatic water you add. Draw volume is your target amount divided by that concentration. Units are draw volume times 100, because a U-100 syringe reads 100 units per millilitre. Common vials for Semax: 10 mg.

Open the Semax calculator → Unit converter

Storage and stability

Dry powder
Cold, dark and dry. Lyophilized peptide is the stable form — keep it that way until you intend to use it.
After reconstitution
Refrigerate at 2–8 °C, protect from light, and plan around a limited window. Do not freeze a reconstituted vial — freeze-thaw damages peptides.
Mixing
Run bacteriostatic water down the inside wall of the vial rather than onto the powder, then swirl. Never shake.
Inspect before use
A clear solution is expected. Cloudiness or particles mean discard, not use.

Full storage guide → · Cloudy solution?

Reported effects

  • The Russian clinical literature reports a favourable tolerability profile.
  • Independent Western replication is limited, which is the main weakness in the evidence base rather than any specific safety finding.
  • No approval outside Russia and neighbouring countries.

Sourcing Semax

Whatever you are working with, the documentation matters more than the price. Ask for a batch certificate of analysis whose lot number matches the vial you actually receive — a COA for a different batch tells you nothing about yours.

Semax at Summit Research Supply → Grade a COA first

Summit is the supplier we feature and an affiliate link. Our COA checklist applies the same way to any vendor.

Sources and further reading

For laboratory research use only. This page documents what the published literature reports about Semax. It is not a recommendation, not a treatment plan, and not medical advice. Compounds referenced are sold strictly as research chemicals and are not for human or veterinary use. Some supplier links are affiliate links and may earn us a commission. This never affects tier placement or review conclusions.
Summit Research Supply
Summit Research Supply — COA-verified research peptidesThird-party tested · U.S. fulfillment · new researchers save 10%
Shop →